Curis
CRIS
#10633
Rank
A$18.13 M
Marketcap
A$0.47
Share price
55.98%
Change (1 day)
-86.00%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -A$50.91 Million

According to Curis's latest financial reports the company's current earnings are A$11.65 Million. In 2024 the company made an earning of -A$61.98 Million, an increase over its 2023 earnings that were of -A$65.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$50.91 Million-17.87%
2024 -A$61.98 Million-5.77%
2023 -A$65.78 Million-13.1%
2022 -A$75.69 Million27.52%
2021 -A$59.36 Million65.09%
2020 -A$35.96 Million-9.1%
2019 -A$39.56 Million-4.73%
2018 -A$41.52 Million-41.95%
2017 -A$71.51 Million-14.37%
2016 -A$83.52 Million3.55%
2015 -A$80.65 Million271.52%
2014 -A$21.71 Million76.64%
2013 -A$12.29 Million
2011 -A$10.44 Million27.76%
2010 -A$8.17 Million-43.87%
2009 -A$14.56 Million-23.44%
2008 -A$19.02 Million56.66%
2007 -A$12.14 Million-16.71%
2006 -A$14.57 Million-36.92%
2005 -A$23.1 Million156.25%
2004 -A$9.02 Million-37.24%
2003 -A$14.37 Million-93.34%
2002 -A$0.22 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.34 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.90 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$89.67 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.45 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.42 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$35.89 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA